Ocera Therapeutics Inc. (OCRX) stock coverage initiated with “Buy” in note to investors by HC Wainwright

HC Wainwright (Ocera Therapeutics Inc.: NASDAQ) shares rose on Wednesday Dec 28 with heavier trade volume than normal after more analysts initiated coverage on the stock.

Meanwhile, U.S. stocks were little changed on Wednesday, as investors found few reasons to keep pushing shares higher towards the 20,000 mark.

The Dow Jones Industrial Average DJIA, -0.11% rose 3.1 points to 19,949, essentially unchanged on the day. The S&P 500 SPX, -0.39% lost 3 points, or 0.1%, to 2,266 while the Nasdaq Composite Index COMP, -0.59% slipped 6.4 points, or 0.1%, to 5,482.

Analysts at HC Wainwright initiated coverage on HC Wainwright (Ocera Therapeutics Inc.: NASDAQ) stock, rating the company at Buy. With a rating of Buy on the shares, the company has a 52-week high of $3.90. As a means of comparison, a number of other analysts have spoken on the company in recent days, and the company has earned a consensus one-year price target of $8.75, higher than the opening price of $2.75. After beginning or initiating coverage, analysts and brokerage firms will subsequently publish periodic updates. Changes in price targets are not unusual.

HC Wainwright (Ocera Therapeutics Inc.: NASDAQ) shares last traded at $2.65, a spike of $0.45 or 20.45% compared to the previous closing price. Opening at $2.75, they fluctuated from $2.55 and $2.95 throughout the day.

HC Wainwright (Ocera Therapeutics Inc.: NASDAQ) now has a market cap of 61.33M.

HC Wainwright (Ocera Therapeutics Inc.: NASDAQ) Average Daily Trading Volume

The stock’s average daily volume is 266,968 shares out of a total float 12,095,000 and some 954,690 shares crossed the trading desk yesterday, higher than the norm. Heavy volume accumulation by institutional investors may be in the near future as the combination of significant increases in trading volume and price growth can be deciding components.

While increased trading for short periods will not mean much, however, a trend of heavy trading volume on the buy side over a series of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is crucial.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors retain teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.

HC Wainwright (Ocera Therapeutics Inc.: NASDAQ) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By identifying trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.

Trades for HC Wainwright (Ocera Therapeutics Inc.: NASDAQ) have ranged from $1.76 – 3.90, and the stock now has a 50-day MA of $2.23 and 200-day MA of $2.39. Today’s last price is 32.05%% under the 52 week high of $3.90.

Indeed, earnings growth is among the most important things to look at in regards to stock investing and, accordingly, investors identify companies that have raised their earnings at least 25% or more for a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *